Specifically, TAPBP, TMEM184B and BGN were all significantly highly expressed in ANCA-GN tissues, whereas CYP3A5 and SLC12A3 demonstrated significantly lower expression levels. The gene discussed is SLC12A3; the disease is ganglioneuroma.